Assessing in vitro long-term liver metabolism models to characterize intrinsic clearance determination in NGRAs.
- 1Beiersdorf AG, Hamburg, Germany.
- 2SWS, Erzhausen, Germany.
Abstract
In Next Generation Risk Assessments, measurements of hepatic intrinsic clearance (CLint , in vitro ) and metabolite(s) formation can markedly impact in vitro to in vivo extrapolations and subsequent testing of parent and/or metabolites in in vitro bioassays. It is especially important for slowly metabolized chemicals to use the most suitable model and experimental design to ensure that the IVIVE is accurate. We evaluated four long-term hepatic models (sandwich cultures of primary human hepatocytes (PHH), HepatoPac, HµREL and TruVivo), as well as PHH suspensions, using salicylic acid, 1-methyl-2-pyrrolidinone (NMP) and valproic acid. Assay designs differed in terms of positive and negative controls, cell densities and incubation durations. All models generated a measurable CLint , in vitro value for salicylic acid i.e. depletion >20%. Differences may be due to donor differences and the cell number. HepatoPac generally resulted in higher values compared with the other models. NMP was not metabolized by HµREL and TruVivo models and a reliable value was only possible using HepatoPac. NMP was metabolized by sandwich cultures; however, the half-life was much longer than the incubation duration. To derive a more robust value, follow up testing could include longer incubation times. Valproic acid was only metabolized in one of the three models in which it was detected, namely sandwich cultures. In conclusion, PHH sandwich cultures, HepatoPac, HµREL and TruVivo models are superior to PHH suspensions with respect to maintaining XME activities over days and for measuring CLint, in vitro values for slowly metabolized chemicals. To gain regulatory acceptance and better interpret data from different labs, we recommend increasing the number of chemicals tested and harmonization of protocols.
Related
- Assessing the Incidence, Persistence and Clearance of Oral HPV Detection Among Metropolitan and Non-Metropolitan Indigenous Australian Adults.
- A systematic review to characterize functional tic-like behaviors
- Instrumental and sensory methodologies to characterize the residual film of topical products applied to skin
- Apparent diffusion coefficient histogram parameters of the whole tumor based on whole-body magnetic resonance imaging can better characterize the tumor burden of multiple myeloma and predict survival prognosis
- Divergent ectopic fat distribution and adipokine/hepatokine levels characterize the metabolically healthy overweight/obesity phenotype
BibTeX
@article{meinhardt2026assessing,
title = {{Assessing in vitro long-term liver metabolism models to characterize intrinsic clearance determination in NGRAs.}},
author = {Jaqueline Meinhardt and Abdulkarim Najjar and Nicola J Hewitt and Andreas Schepky and Daniela Lange},
journal = {NAM journal},
year = {2026},
month = sep,
doi = {10.1016/j.namjnl.2026.100139},
url = {https://europepmc.org/article/MED/42894759},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Assessing in vitro long-term liver metabolism models to characterize intrinsic clearance determination in NGRAs.
AU - Jaqueline Meinhardt
AU - Abdulkarim Najjar
AU - Nicola J Hewitt
AU - Andreas Schepky
AU - Daniela Lange
PY - 2026
DA - 2026/09/30
JO - NAM journal
DO - 10.1016/j.namjnl.2026.100139
UR - https://europepmc.org/article/MED/42894759
AB - In Next Generation Risk Assessments, measurements of hepatic intrinsic clearance (CLint , in vitro ) and metabolite(s) formation can markedly impact in vitro to in vivo extrapolations and subsequent testing of parent and/or metabolites in in vitro bioassays. It is especially important for slowly metabolized chemicals to use the most suitable model and experimental design to ensure that the IVIVE is accurate. We evaluated four long-term hepatic models (sandwich cultures of primary human hepatocytes (PHH), HepatoPac, HµREL and TruVivo), as well as PHH suspensions, using salicylic acid, 1-methyl-2-pyrrolidinone (NMP) and valproic acid. Assay designs differed in terms of positive and negative controls, cell densities and incubation durations. All models generated a measurable CLint , in vitro value for salicylic acid i.e. depletion >20%. Differences may be due to donor differences and the cell number. HepatoPac generally resulted in higher values compared with the other models. NMP was not metabolized by HµREL and TruVivo models and a reliable value was only possible using HepatoPac. NMP was metabolized by sandwich cultures; however, the half-life was much longer than the incubation duration. To derive a more robust value, follow up testing could include longer incubation times. Valproic acid was only metabolized in one of the three models in which it was detected, namely sandwich cultures. In conclusion, PHH sandwich cultures, HepatoPac, HµREL and TruVivo models are superior to PHH suspensions with respect to maintaining XME activities over days and for measuring CLint, in vitro values for slowly metabolized chemicals. To gain regulatory acceptance and better interpret data from different labs, we recommend increasing the number of chemicals tested and harmonization of protocols.
SN - 3050-6204
ER -